Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL

TP53 aberrations, including mutations and deletion of 17p13, are important adverse prognostic markers in chronic lymphocytic leukemia (CLL) but are less studied in high count monoclonal B-cell lymphocytosis (HCMBL), an asymptomatic pre-malignant stage of CLL. Here we estimated the prevalence and imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffin, Rosalie, Wiedmeier-Nutor, Julia E., Parikh, Sameer A., McCabe, Chantal E., O'Brien, Daniel R., Boddicker, Nicholas J., Kleinstern, Geffen, Rabe, Kari G., Bruins, Laura, Brown, Sochilt, Bonolo de Campos, Cecilia, Ding, Wei, Leis, Jose F., Hampel, Paul J., Call, Timothy G., Van Dyke, Daniel L., Kay, Neil E., Cerhan, James R., Yan, Huihuang, Slager, Susan L., Braggio, Esteban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338209/
https://www.ncbi.nlm.nih.gov/pubmed/36877634
http://dx.doi.org/10.1182/bloodadvances.2022009040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338209/
https://www.ncbi.nlm.nih.gov/pubmed/36877634
http://dx.doi.org/10.1182/bloodadvances.2022009040

Ejemplares similares